GlobeStar Therapeutics Corporation (GSTC)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 2, 2026
-99.67%
Market Cap 1.24K
Revenue (ttm) n/a
Net Income (ttm) -919.30K
Shares Out 1.24B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 66,000
Average Volume 808,307
Open 0.0000
Previous Close n/a
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0003
Beta 1.42
RSI 44.13
Earnings Date Jan 21, 2026

About GlobeStar Therapeutics

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, engages in the provision of patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases in the United States. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in New York, New York. [Read more]

Industry Biotechnology
Sector Healthcare
CEO James Katzaroff
Country United States
Stock Exchange OTCMKTS
Ticker Symbol GSTC
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.